Evidence and Controversies in the Use of Post-Mastectomy Radiation

Authors:
Shaneli A. FernandoFrom the Departments of Radiation Medicine and Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, and the Department of Surgery, University at Buffalo, Buffalo, New York.

Search for other papers by Shaneli A. Fernando in
Current site
Google Scholar
PubMed
Close
 MD
and
Stephen B. EdgeFrom the Departments of Radiation Medicine and Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, and the Department of Surgery, University at Buffalo, Buffalo, New York.
From the Departments of Radiation Medicine and Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, and the Department of Surgery, University at Buffalo, Buffalo, New York.

Search for other papers by Stephen B. Edge in
Current site
Google Scholar
PubMed
Close
 MD
Full access

Radiation after mastectomy is recommended for women with positive nodes, larger tumors, or positive margins. In addition to its role in reducing the risk for locoregional recurrence, it has an additive effect to the survival benefit seen with adjuvant systemic therapy. This article reviews the role of post-mastectomy radiation (PMRT) based on the recommendations in the 2007 NCCN Breast Cancer Clinical Practice Guidelines in Oncology and addresses the risk factors for recurrence after mastectomy. The data supporting both improvement in locoregional failure and survival are reviewed in detail. This article also discusses controversial areas in PMRT, including regional nodal radiation in women with 1 to 3 positive lymph nodes, PMRT in node-negative women with large tumors, and inclusion of internal mammary nodes. The final section discusses radiation field design and potential complications.

Correspondence: Shaneli A. Fernando, MD, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. E-mail: Shaneli.Fernando@roswellpark.org
  • Collapse
  • Expand
  • 1.

    Carlson RW, Anderson BO, Burstein HJ et al.. NCCN breast cancer clinical practice guidelines in oncology. Version 1, 2007. Available at: http://www.nccn.org/physician_gls/PDF/breast.pdf. Accessed January 25, 2007.

    • Search Google Scholar
    • Export Citation
  • 2.

    Recht A, Gray R, Davidson NE et al.. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999;17:16891700.

    • Search Google Scholar
    • Export Citation
  • 3.

    Jagsi R, Raad RA, Goldberg S et al.. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 2005;62:10351039.

    • Search Google Scholar
    • Export Citation
  • 4.

    Katz A, Strom EA, Buchholz TA et al.. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000;18:28172827.

    • Search Google Scholar
    • Export Citation
  • 5.

    Katz A, Strom EA, Buchholz TA et al.. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001;50:735742.

    • Search Google Scholar
    • Export Citation
  • 6.

    Taghian A, Jeong JH, Mamounas E et al.. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004;22:42474254.

    • Search Google Scholar
    • Export Citation
  • 7.

    Wallgren A, Bonetti M, Gelber RD et al.. Risk factors for locoregional recurrence among breast cancer patients: results from international breast cancer study group trials I through VII. J Clin Oncol 2003;21:12051213.

    • Search Google Scholar
    • Export Citation
  • 8.

    Overgaard M, Jensen MB, Overgaard J et al.. Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 1999;353:16411648.

    • Search Google Scholar
    • Export Citation
  • 9.

    Ragaz J, Jackson SM, Le N et al.. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:936962.

    • Search Google Scholar
    • Export Citation
  • 10.

    Ragaz J, Olivotto IA, Spinell JJ et al.. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116126.

    • Search Google Scholar
    • Export Citation
  • 11.

    Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000;355:17571770.

    • Search Google Scholar
    • Export Citation
  • 12.

    Clarke M, Collins R, Darby C et al.. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005;366:20872106.

    • Search Google Scholar
    • Export Citation
  • 13.

    Overgaard M, Hansen PS, Overgaard J et al.. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949955.

    • Search Google Scholar
    • Export Citation
  • 14.

    Whelan TJ, Julian J, Wright J et al.. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000;18:12201229.

    • Search Google Scholar
    • Export Citation
  • 15.

    Benson EA, Thorogood J. The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Onc 1986;12:267271.

    • Search Google Scholar
    • Export Citation
  • 16.

    Helinto M, Blomqvist C, Heikkila P, Joensuu H. Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed? Radiother Oncol 1999;52:213217.

    • Search Google Scholar
    • Export Citation
  • 17.

    Taghian AG, Jeong JH, Manmouas EP et al.. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2006;24:39273932.

    • Search Google Scholar
    • Export Citation
  • 18.

    Floyd SR, Buchholz TA, Haffty BG et al.. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys 2006;66:358364.

    • Search Google Scholar
    • Export Citation
  • 19.

    Freedman GM, Fowble BL, Hanlon AL et al.. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys 1998;4l:599605.

    • Search Google Scholar
    • Export Citation
  • 20.

    Strom EA, McNeese MD. Postmastectomy irradiation rationale for treatment field selection. Semin Radiat Oncol 1999;9:247253.

  • 21.

    Strom EA, Woodward WA, Katz A et al.. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:15081513.

    • Search Google Scholar
    • Export Citation
  • 22.

    Pierce LJ, Oberman HA, Strawderman MH, Lichter AS. Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy? Int J Radiat Oncol Biol Phys 1995;33:253259.

    • Search Google Scholar
    • Export Citation
  • 23.

    Rech A, Edge SB, Solin LJ et al.. Postmastectomy radiotherapy: guidelines for the American Society of Clinical Oncology. J Clin Oncol 2001;19:15891569.

    • Search Google Scholar
    • Export Citation
  • 24.

    Lingos TI, Recht A, Vacini F. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1991;21:355360.

    • Search Google Scholar
    • Export Citation
  • 25.

    Marks LB. Pulmonary effects of thoracic irradiation. Oncology 1994;8:89100.

  • 26.

    Burstein HJ, Bellon JR, Galper S et al.. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast cancer. Int J Radiat Oncol Biol Phys 2006;64:496504.

    • Search Google Scholar
    • Export Citation
  • 27.

    Halyard M, Pisansky L, Solin U et al.. Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer; toxicity data from the North Central Cancer Treatment Group Phase III trial N9831. J Clin Oncol 2006;24(suppl 1):8S. Abstract 523.

    • Search Google Scholar
    • Export Citation
  • 28.

    Nixon AJ, Manola J, Gelman R. No long term increase in cardiac-related mortality after breast conserving surgery and radiation using modern techniques. J Clin Oncol 1998;16:13741379.

    • Search Google Scholar
    • Export Citation
  • 29.

    Harris EE, Correa C, Hwang WT et al.. Late cardiac mortality and morbidity in early stage breast cancer patients after breast conservation treatment. J Clin Oncol 2006;24:41004106.

    • Search Google Scholar
    • Export Citation
  • 30.

    Larson D, Weinstein M, Goldberg I. Edema of the arm as a function of the extent of axillary surgery in patient with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:15751582.

    • Search Google Scholar
    • Export Citation
  • 31.

    Hinrichs CS, Watroba NL, Rezaishiraz H et al.. Lymphedema secondary to post-mastectomy radiation: incidence and risk factors. Ann Surg Oncol 2004;11:573580.

    • Search Google Scholar
    • Export Citation
  • 32.

    Yeoh EK, Denham JW, Davies SA, Spittle MF. Primary breast cancer. Complications of axillary management. Acta Radiol Oncol 1986;25:105108.

  • 33.

    Emami B, Lyman J, Brown A et al.. Tolerance of normal tissues to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109122.

  • 34.

    Taghian A, de Vathaire F, Terrier P et al.. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 1991;21:361367.

    • Search Google Scholar
    • Export Citation
  • 35.

    Neugut AI, Robinson E, Lee WC et al.. Lung cancer after radiation therapy for breast cancer. Cancer 1993;71:30543057.

  • 36.

    Chawla AK, Kachnic LA, Taghian AG et al.. Radiotherapy and breast reconstruction: complication and cosmesis with TRAM versus tissue expander/implant. Int J Radiat Oncol Biol Phys 2002;54:520526.

    • Search Google Scholar
    • Export Citation
  • 37.

    Krueger EA, Wilkinson EG, Strawderman MH et al.. Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys 2001;49:713721.

    • Search Google Scholar
    • Export Citation
  • 38.

    Ascherman JA, Hanasono MM, Newman MI, Hughes DB. Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg 2006;117:359365.

    • Search Google Scholar
    • Export Citation
  • 39.

    Motwani SB, Strom EA, Schechter NR et al.. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:7682.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 271 113 12
PDF Downloads 128 47 1
EPUB Downloads 0 0 0